Search Results 201-210 of 85371 for Active

1. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Clinical Trials · A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease · More ...

2. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis · Overview.

3. Women's Wellness: Birth control pill benefits, risks and choices - Mayo Clinic News Network

   ... active pills. Some extended-cycle pill regimens have active hormone pills every day for three months, followed by a week of placebo or low-dose estrogen pills.

4. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis ... active ulcerative colitis (UC).

5. Loss of sex drive in men: Natural with aging? - Mayo Clinic

   If a reversible cause for low testosterone isn't found, testosterone replacement therapy might return your testosterone level and sex drive to normal. If a ...

6. Abatacept (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   ... active polyarticular juvenile idiopathic arthritis (pJIA). Abatacept injection is also used alone or together with other medicines to treat active psoriatic ...

7. Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease - Mayo Clinic

   The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease. The study will test ...

8. A Study Investigating Oral Ozanimod (RPC1063) In Pediatric Participants With Moderate To Severe Active Ulcerative Colitis - Mayo Clinic

   Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to ...

9. A Study to Assess the Effectiveness and Safety of Intravitreal 440 ug DE-109 Sirolimus Injections for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye - Mayo Clinic

   A Study to Assess the Effectiveness and Safety of Intravitreal 440 ug DE-109 Sirolimus Injections for the Treatment of Active, Non-Infectious Uveitis of the ...

10. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease ... active Crohn's disease (CD) in ...